Ken Griffin Bio Sig Technologies, Inc. Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.62 $20,086 - $47,897	77,254 New	77,254 $37,000
Q2 2023 Aug 14, 2023	BUY	$1.07 - $1.55 $28,103 - $40,710	26,265 New	26,265 $32,000
Q3 2022 Nov 14, 2022	BUY	$0.56 - $6.98 $12,194 - $151,996	21,776 New	21,776 $14,000
Q1 2022 May 16, 2022	BUY	$0.99 - $2.44 $44,106 - $108,706	44,552 Added 42.51%	149,362 $172,000
Q4 2021 Feb 14, 2022	BUY	$2.18 - $3.93 $137,117 - $247,189	62,898 Added 150.07%	104,810 $233,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $4.35 $80,820 - $129,730	29,823 Added 246.7%	41,912 $125,000
Q1 2021 May 17, 2021	SELL	$3.99 - $5.53 $21,342 - $29,579	-5,349 Reduced 30.67%	12,089 $52,000
Q4 2020 Feb 16, 2021	SELL	$2.99 - $5.79 $1,650 - $3,196	-552 Reduced 3.07%	17,438 $68,000
Q1 2020 May 15, 2020	BUY	$2.56 - $6.14 $46,054 - $110,458	17,990 New	17,990 $75,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $60.1M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.